Key result
ADIPOQ rs822396G allele linked to ~400% higher odds of decreased adiponectin in Mexican adolescents.
Why the study?
Variants in ADIPOQ may influence gene expression and serum adiponectin levels, contributing to the development of metabolic syndrome components and cardiometabolic disorders in Mexican adolescents.
Are genetic variants in ADIPOQ and serum adiponectin levels associated with metabolic syndrome components in Mexican adolescents?
Cross-Sectional (n=494)
Are genetic variants in ADIPOQ and serum adiponectin levels associated with metabolic syndrome components in Mexican adolescents?
Variants in the ADIPOQ gene, particularly the rs822396G allele, are associated with lower serum adiponectin levels and metabolic syndrome components in Mexican adolescents.
ADIPOQ variants link to lower adiponectin and dyslipidemia in Mexican adolescents; leaves open causality and screening utility pending longitudinal data.
Background: Variants in ADIPOQ may affect gene expression and serum adiponectin levels (SAL), contributing to the development of metabolic syndrome (MetS) components and cardiometabolic disorders in Mexican adolescents. Aim: To evaluate the association of the genetic variants rs266729, rs822396, rs2241766, and rs1501299 in ADIPOQ , their haplotypes, and SAL with MetS components and cardiometabolic parameters in adolescents from western Mexico. Materials and Methods: A total of 494 adolescents from Jalisco, Mexico, aged 10–17 years, were studied. The biochemical and clinical characteristics of cardiometabolic disorders were diagnosed based on age-, sex-, and population-specific percentiles. Peripheral blood samples were obtained. Serum was separated and SAL were measured by ELISA. DNA was extracted and genotyped using real-time polymerase chain reaction for allelic discrimination. Hardy–Weinberg equilibrium was assessed, and associations were analyzed using logistic regression and Spearman correlations, with a 95% statistical confidence level. Results: SAL were lower in adolescents with MetS ( P = 0.03) and low high-density lipoprotein ( P = 0.01). The rs266729G allele was associated with very low-density lipoprotein >30 mg/dL in the additive inheritance model [AIM; odds ratio (OR) = 1.59, 95% confidence interval (CI) = 1.01–2.53, P = 0.04], dominant inheritance model (DIM; OR = 2.26, 95% CI = 1.07–4.73, P = 0.03), and codominant inheritance model (OR = 2.23, 95% CI = 1.03–4.81, P = 0.04). The rs822396G allele was associated with decreased SAL in AIM (OR = 5.00, 95% CI = 1.69–14.7, P = 0.004) and DIM (OR = 5.23, 95% CI = 1.41–21.6, P = 0.01). The rs2241766G allele (recessive model) was associated with increased alanine aminotransferase levels (OR = 3.73, 95% CI = 1.10–12.6, P = 0.03) and correlated with higher SAL ( R = 0.202, P = 0.045). In controls, the haplotype rs822396–rs2241766–rs1501299 is in linkage disequilibrium ( D ′ = 1), but the correlation is low ( R 2 < 0.1), while in MetS adolescents, D ′ was incomplete. Several haplotypes were associated with cardiometabolic parameters. Conclusion: The variants in ADIPOQ , are associated with MetS and low SAL. The rs822396G allele appears to be a key factor for low SAL and its association with cardiometabolic parameters. The rs2241766T allele was linked to low SAL and clinical characteristics of MetS.
No takes yet. Share an insight, caveat, or question.
Ortega-Pacheco et al. (2025) conducted a cross-sectional in Metabolic syndrome and cardiometabolic disorders (n=494). ADIPOQ genetic variants (rs266729, rs822396, rs2241766, rs1501299) vs. Non-carriers / Controls was evaluated on Decreased serum adiponectin levels (rs822396G allele, additive inheritance model) (OR 5.00, 95% CI 1.69-14.7, p=0.004). The ADIPOQ rs822396G allele was significantly associated with decreased serum adiponectin levels (OR 5.00; 95% CI 1.69-14.7; P=0.004) and cardiometabolic parameters in Mexican adolescents.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: